Performance of the National Institute of Infectious Diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis.
Disability evaluation
Evaluation study
HTLV-1-associated myelopathy
Psychometrics
Journal
Journal of neurovirology
ISSN: 1538-2443
Titre abrégé: J Neurovirol
Pays: United States
ID NLM: 9508123
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
29
01
2023
accepted:
15
06
2023
revised:
05
06
2023
medline:
15
11
2023
pubmed:
4
7
2023
entrez:
3
7
2023
Statut:
ppublish
Résumé
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic disabling disease. However, there is a lack of an adequate and specific health measurement instrument validated and with good performance to assess their degree of physical disability. This led us to carry out this study and to evaluate the performance of Fiocruz's National Institute of Infectious Diseases (IDS) disability scale, a specific instrument for HAM/TSP. Ninety-two HAM/TSP patients participated in the study. One researcher applied the IDS, IPEC scale, Disability Status Scale (DSS), Expanded DSS (EDSS), Osame scale, Beck Depression Inventory, and the WHOQOL-BREF questionnaire. In parallel, blindly, and separately, other researchers applied the IDS. An inter-rater reliability analysis of the IDS, correlation analysis with the other scales, and depression and quality of life questionnaires were performed. The applicability of the IDS was also evaluated. The IDS showed high reliability in all scores. The inter-rater reliability test for the total IDS score was 0.94 (0.82-0.98) on its four dimensions. The scale adequately indicated the different degrees of disability, presenting a distribution similar to normal. There was a high correlation with the other scales (Spearman coefficients > 0.80, p < 0.001). The scale had good acceptance among users and a short application time. IDS for HAM/TSP was reliable, consistent, easy, and fast to use. It can be used for both prospective evaluations and clinical trials. The present study supports the IDS as a valid instrument to measure disability in patients with HAM/TSP compared to previously used scales.
Identifiants
pubmed: 37400732
doi: 10.1007/s13365-023-01154-y
pii: 10.1007/s13365-023-01154-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
555-563Subventions
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico
ID : 307045/2016-1
Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2023. The Author(s) under exclusive licence to The Journal of NeuroVirology, Inc.
Références
Alreck PL, Settle RB (2004) The survey research handbook, 3rd edn. McGraw-Hill/Irwin, Boston
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders -DSM-5, 5th edn. Washington, DC
Araujo AQC, Silva MTT (2006) The HTLV-1 neurological complex. Lancet Neurol 5:1068–1076. https://doi.org/10.1016/S1474-4422(06)70628-7
doi: 10.1016/S1474-4422(06)70628-7
pubmed: 17110288
Castro N, Oliveira P, Freitas D et al (2005) Erectile dysfunction and HTLV-I infection: a silent problem. Int J Impot Res 17:364–369. https://doi.org/10.1038/sj.ijir.3901335
doi: 10.1038/sj.ijir.3901335
pubmed: 15875060
Costa D, Castro N, Tannus M et al (2011) Neurological disability in HTLV-1 infected individuals according to the initial clinical presentation: cohort study. Retrovirology 8:A62. https://doi.org/10.1186/1742-4690-8-S1-A62
doi: 10.1186/1742-4690-8-S1-A62
pmcid: 3112777
Eisen M, Ware JE, Donald CA, Brook RH (1979) Measuring components of children’s health status. Med Care 17:902–921. https://doi.org/10.1097/00005650-197909000-00003
doi: 10.1097/00005650-197909000-00003
pubmed: 480998
Fleck MP, Louzada S, Xavier M et al (2000) Application of the Portuguese version of the abbreviated instrument of quality life WHOQOL-bref. Rev Saude Publica 34:178–183. https://doi.org/10.1590/s0034-89102000000200012
doi: 10.1590/s0034-89102000000200012
pubmed: 10881154
Franzoi AC, Araújo AQC (2007) Disability and determinants of gait performance in tropical spastic paraparesis/HTLV-I associated myelopathy (HAM/TSP). Spinal Cord 45:64–68. https://doi.org/10.1038/sj.sc.3101919
doi: 10.1038/sj.sc.3101919
pubmed: 16568145
Gascón MRP, Capitão CG, Casseb J et al (2011) Prevalence of anxiety, depression and quality of life in HTLV-1 infected patients. Braz J Infect Dis 15:578–582. https://doi.org/10.1590/s1413-86702011000600013
doi: 10.1590/s1413-86702011000600013
pubmed: 22218518
Gorenstein C, Andrade L (1996) Validation of a Portuguese version of the Beck Depression Inventory and the State-Trait Anxiety Inventory in Brazilian subjects. Braz J Med Biol Res 29:453–457
pubmed: 8736107
Gorenstein C, Andrade LHSG de (1998) Inventario de depressao de Beck: propriedades psicometricas da versao em portugues. Rev psiquiatr clín (São Paulo) 245–50
Hobart J, Freeman J, Thompson A (2000) Kurtzke scales revisited: the application of psychometric methods to clinical intuition. Brain 123(Pt 5):1027–1040. https://doi.org/10.1093/brain/123.5.1027
doi: 10.1093/brain/123.5.1027
pubmed: 10775547
Khanna D, Tsevat J (2007) Health-related quality of life–an introduction. Am J Manag Care 13(Suppl 9):S218-223
pubmed: 18095785
Koo TK, Li MY (2016) A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med 15:155–163. https://doi.org/10.1016/j.jcm.2016.02.012
doi: 10.1016/j.jcm.2016.02.012
pubmed: 27330520
pmcid: 4913118
Kurtzke JF (1955) A new scale for evaluating disability in multiple sclerosis. Neurology 5:580–583. https://doi.org/10.1212/wnl.5.8.580
doi: 10.1212/wnl.5.8.580
pubmed: 13244774
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452. https://doi.org/10.1212/wnl.33.11.1444
doi: 10.1212/wnl.33.11.1444
pubmed: 6685237
Lima M, a. SD, Bica RBS, Araújo AQC (2005) Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis. Journal of Neurology, Neurosurgery & Psychiatry 76:294–296. https://doi.org/10.1136/jnnp.2004.035709
doi: 10.1136/jnnp.2004.035709
Martin F, Castro H, Gabriel C et al (2012) Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis. PLoS Negl Trop Dis 6:e1675. https://doi.org/10.1371/journal.pntd.0001675
McHorney CA, Tarlov AR (1995) Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res 4:293–307. https://doi.org/10.1007/BF01593882
doi: 10.1007/BF01593882
pubmed: 7550178
McHorney CA, Ware JE, Lu JF, Sherbourne CD (1994) The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40–66. https://doi.org/10.1097/00005650-199401000-00004
doi: 10.1097/00005650-199401000-00004
pubmed: 8277801
Olindo S, Cabre P, Lézin A et al (2006) Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study. Arch Neurol 63:1560–1566. https://doi.org/10.1001/archneur.63.11.1560
doi: 10.1001/archneur.63.11.1560
pubmed: 17101824
Oliveira P, de Castro NM, Carvalho EM (2007) Urinary and sexual manifestations of patients infected by HTLV-I. Clinics 62:191–196. https://doi.org/10.1590/S1807-59322007000200015
doi: 10.1590/S1807-59322007000200015
pubmed: 17505705
Osame M (1990) Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Human Retrovirology: HTLV 1st edn. William Blattner, New York, p 484
Osame M, Janssen R, Kubota H et al (1990) Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Ann Neurol 28:50–56. https://doi.org/10.1002/ana.410280110
doi: 10.1002/ana.410280110
pubmed: 2375633
Portney LG, Watkins MP (2015) Foundations of clinical research: applications to practice, 3rd edition, [revised]. Pearson/Prentice Hall, Upper Saddle River, N.J
Schmidt F, Oliveira AL, Araujo A (2012) Development and validation of a neurological disability scale for patients with htlv-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): The IPEC-1 Scale (P03.258). Neurology 78:P03.258-P03.258
Sharrack B, Hughes RA (1996) Clinical scales for multiple sclerosis. J Neurol Sci 135:1–9. https://doi.org/10.1016/0022-510x(95)00261-y
doi: 10.1016/0022-510x(95)00261-y
pubmed: 8926489
Sharrack B, Hughes RA, Soudain S, Dunn G (1999) The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 122(Pt 1):141–159. https://doi.org/10.1093/brain/122.1.141
doi: 10.1093/brain/122.1.141
pubmed: 10050902
Shrout PE, Fleiss JL (1979) Intraclass correlations: uses in assessing rater reliability. Psychol Bull 86:420–428. https://doi.org/10.1037//0033-2909.86.2.420
doi: 10.1037//0033-2909.86.2.420
pubmed: 18839484
Silva MTT, Espíndola OM, Leite AC et al (2017) Isolated bladder dysfunction in human T lymphotropic virus type 1 infection: 10 years of follow-up. J Neurol Neurosurg Psychiatry 88:278–279. https://doi.org/10.1136/jnnp-2016-314606
doi: 10.1136/jnnp-2016-314606
pubmed: 27815322
Silva MTT, Mattos P, Alfano A, Araújo AQ-C (2003) Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls. J Neurol Neurosurg Psychiatry 74:1085–1089
doi: 10.1136/jnnp.74.8.1085
pubmed: 12876239
pmcid: 1738599
Souza F dos S, Freitas NL, Gomes YCP et al (2021) Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression. Front Immunol 12
Stewart AL, Ware JE (eds) (1992) Measuring functioning and well-being: the medical outcomes study approach. Duke University Press, Durham
Tavares IR, Franzoi AC, Araújo AQ-C (2010) Low-back pain in HTLV-I-associated myelopathy/tropical spastic paraparesis: nociceptive or neuropathic? Spinal Cord 48:134–137. https://doi.org/10.1038/sc.2009.83
doi: 10.1038/sc.2009.83
pubmed: 19581917
Wang Y-P, Gorenstein C (2013) Psychometric properties of the Beck Depression Inventory-II: a comprehensive review. Braz J Psychiatry 35:416–431. https://doi.org/10.1590/1516-4446-2012-1048
doi: 10.1590/1516-4446-2012-1048
pubmed: 24402217
World Health Organization. Division of Mental Health (1996) WHOQOL-BREF : introduction, administration, scoring and generic version of the assessment : field trial version, December 1996. World Health Organization
Yamano Y, Nagai M, Brennan M et al (2002) Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP). Blood 99:88–94. https://doi.org/10.1182/blood.v99.1.88
doi: 10.1182/blood.v99.1.88
pubmed: 11756157